Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The FDA-approved criteria require a BMI of 30 or greater (obesity), or a BMI of 27 or greater with at least one weight-related comorbidity such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease
Semaglutide (PMC, 2025) Real-world HbA1c and weight outcomes: Tirzepatide vs
GLP-1 receptor agonists are a class of injectable medications that mimic the action of a naturally occurring hormone secreted by the small intestine in response to food entering the small intestine
The subscription includes compounded medication at a fixed monthly price, so the cost stays the same even as your dose increasessomething many competitors dont guarantee
US$ 22.44
US$ 27.98
US$ 29.95
